Study guide

2.4 Umbilical Lines, Acid-Base & Laboratory Evaluation

NBRC RRT-NPS Neonatal/Pediatric Specialist Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Neonatal and Pediatric Patient Assessment

1.1 Maternal, Obstetric & Perinatal History 1.2 Fetal Surveillance & Antepartum Diagnostics 1.3 Gestational Age & Baseline Neonatal Examination 1.4 Apgar, Respiratory Distress & Thoracic Assessment 1.5 Pediatric Assessment Triangle & Vital Signs 1.6 Neurologic Assessment, Respiratory Failure & Triage

2 Chapter 2: Diagnostic Evaluation & Gas Exchange Monitoring

2.1 Pulse Oximetry, Pre/Postductal & Transcutaneous Monitoring 2.2 Capnography, Waveforms & Dead-Space Evaluation 2.3 Arterial & Capillary Blood-Gas Sampling 2.4 Umbilical Lines, Acid-Base & Laboratory Evaluation 2.5 Chest Imaging & Airway Radiography 2.6 Pulmonary Function, Bronchoscopy & Specimen Diagnostics

3 Chapter 3: Airway Management & Secretion Clearance

3.1 Pediatric Airway Anatomy & ETT Sizing 3.2 Cuffed Airways, Intubation & Difficult-Airway Management 3.3 Tracheostomy Devices & Routine Care 3.4 Tracheostomy Emergencies, Speaking & Decannulation 3.5 Airway Suctioning Technique & Safety 3.6 Airway Clearance, Home Care & Discharge Planning

4 Chapter 4: Pharmacology & Medical Gas Therapy

4.1 Aerosol Physics & Delivery Devices 4.2 Respiratory & Systemic Pharmacology 4.3 Oxygen Interfaces & Delivery Systems 4.4 Oxygen Blenders, Targets & Toxicity 4.5 HFNC Physiology, Sizing & Flow 4.6 HFNC Indications, Monitoring & Escalation

5 Chapter 5: Shared Neonatal & Pediatric Pulmonary Disorders

5.1 Neonatal RDS Pathophysiology & Management 5.2 TTN, Pneumonia & the Neonatal Differential 5.3 Meconium Aspiration & PPHN 5.4 BPD, Apnea & Chronic Neonatal Lung Disease 5.5 Bronchiolitis, Croup & Epiglottitis 5.6 Asthma, Cystic Fibrosis & Foreign-Body Aspiration

6 Chapter 6: Resuscitation, Emergency Protocols & Patient Safety

6.1 NRP Cord Management, Initial Steps & Ventilation 6.2 NRP Corrective Steps, Compressions & Medications 6.3 PALS Assessment, CPR & Cardiac Arrest 6.4 PALS Dysrhythmia & Shock Management 6.5 Neonatal & Pediatric Transport 6.6 Patient Safety, Teamwork & Family-Centered Care

7 Chapter 7: Noninvasive & Conventional Mechanical Ventilation

7.1 Bubble CPAP & Neonatal NIV 7.2 Pediatric NIV, Interfaces & Failure Recognition 7.3 Conventional Ventilation Physics & Modes 7.4 Initial Settings & ABG-Guided Titration 7.5 Ventilator Scalars & Loops 7.6 Ventilator Dyssynchrony & Troubleshooting 7.7 Weaning Readiness & Spontaneous Breathing Trials 7.8 Extubation & Post-Extubation Airway Risk

8 Chapter 8: High-Frequency Ventilation & Advanced Modes

8.1 HFOV Mechanics & Gas Transport 8.2 HFOV Controls & Clinical Management 8.3 HFJV Circuit & Controls 8.4 HFJV Servo Pressure & Clinical Indications 8.5 NAVA, Edi & Proportional Support 8.6 APRV in Pediatric Respiratory Failure

9 Chapter 9: Specialty Inhaled Gases & Exogenous Surfactant Therapy

9.1 Inhaled Nitric Oxide: Mechanism, Indications & Dose 9.2 Inhaled Nitric Oxide: Toxicity, Monitoring & Weaning 9.3 Heliox Physics & Delivery 9.4 Volatile Anesthetic & Subambient Gas Therapy 9.5 Surfactant Biology, Products & Dosing 9.6 Surfactant Administration & Response

10 Chapter 10: Pediatric ARDS & Parenchymal Critical Illness

10.1 PALICC-2 Diagnosis & Severity 10.2 PALICC-2 NIV & Possible PARDS 10.3 PARDS Lung-Protective Ventilation 10.4 PARDS Refractory Hypoxemia & Adjuncts 10.5 PIE & Pneumothorax Recognition 10.6 Thoracic Decompression & Chest Drains

11 Chapter 11: Congenital Heart Disease & Hemodynamic Management

11.1 Left-to-Right Shunts & Qp/Qs Physiology 11.2 Acyanotic Lesions & Respiratory Management 11.3 Cyanotic Lesions & the Five Ts 11.4 Ductal Dependence, PGE1 & the Hyperoxia Test 11.5 Single-Ventricle Physiology & Staged Palliation 11.6 Gas Balancing, Hemodynamics & NIRS

12 Chapter 12: Advanced Critical Care: ECMO, Neurotrauma & Palliative Care

12.1 ECMO Candidacy & Modality 12.2 ECMO Circuit, Lung Rest & Anticoagulation 12.3 Neurotrauma, ICP & Ventilation 12.4 Neonatal Therapeutic Hypothermia & Respiratory Care 12.5 Death by Neurologic Criteria: Examination & Apnea Testing 12.6 DNC Timing, Ancillary Testing, Palliation & Donation

2.4 Umbilical Lines, Acid-Base & Laboratory Evaluation

Key Takeaways Explain This Topic AI

Verify a UAC tip in an accepted high or low zone and reposition an intermediate tip near major abdominal branch vessels before use.

Interpret blood gases and laboratory trends against gestational age, diagnosis, support, sampling site, and the patient rather than treating one reference range as universal.

A high umbilical arterial catheter tip sits at T6 to T9 and a low tip at L3 to L4; a tip at T10 to L2 overlaps the celiac, superior mesenteric, and renal branches and must be repositioned before use.

Winter's formula predicts the compensatory PaCO2 in metabolic acidosis as (1.5 x HCO3-) + 8 plus or minus 2, so a measured PaCO2 above that range signals a superimposed respiratory acidosis.

Last updated: September 2026

  • 2.4 Umbilical Lines, Acid-Base & Laboratory Evaluation
  • Umbilical Artery Catheterization (UAC)

In critically ill neonates, umbilical arterial catheterization provides continuous arterial blood pressure monitoring, frequent blood gas sampling without painful stimuli, and intravascular access.

Vascular Anatomy & Route

The umbilical cord contains two thick-walled umbilical arteries and one thin-walled umbilical vein . An inserted UAC navigates through the following anatomical vessels:

  • Umbilical Ring ──► Internal Iliac (Hypogastric) Artery ──► Common Iliac Artery ──► Abdominal Aorta
  • Radiographic Verification & Vertebral Levels Vertebral Level Vascular Structures UAC Placement Zone
  • ────────────────────────────────────────────────────────────────────────
  • T4 Ductus Arteriosus
  • T6–T9 ◄ HIGH LINE (Preferred)
  • ────────────────────────────────────────────────────────────────────────
  • T12 Celiac Axis ▲
  • L1 Superior Mesenteric Artery │ DANGEROUS 'NO-FLY ZONE'
  • L1–L2 Renal Arteries ▼ (Risk of Thrombosis)
  • ────────────────────────────────────────────────────────────────────────
  • L3–L4 ◄ LOW LINE (Acceptable)
  • L4–L5 Aortic Bifurcation

High-line position: A commonly accepted target is T6 to T9 , above the major abdominal arterial branches. High lines generally have fewer vascular complications than low lines.

Low-line position: A commonly accepted target is L3 to L4 , below the renal and mesenteric branches and above the aortic bifurcation.

Intermediate malposition: A tip around T10 to L2 overlaps major branch vessels and should be repositioned before use. Confirm the image, anatomy, and local radiographic criteria after adjustment.

Complications & Troubleshooting

Limb ischemia or vasospasm: New blanching, cyanosis, coolness, weak pulses, or delayed refill after UAC placement requires immediate perfusion assessment, notification of the neonatal team, and action under the catheter protocol. Stop any nonessential infusion through the line, verify position and other causes, and remove or reposition the catheter promptly when perfusion remains impaired. Do not warm the ischemic limb or delay escalation while waiting for a fixed interval; contralateral warming appears in older protocols but is not a substitute for catheter management.

Vascular Thromboembolism: Risk of aortic thrombosis or microemboli to extremities.

Hemorrhage: Accidental luer-lock disconnection can result in fatal neonatal exsanguination within minutes. All catheter stopcocks and connections must be locked, visible, and equipped with continuous pressure monitoring alarms.

Blood-Gas Reference and Treatment Ranges

Interpreting blood gas values requires age-adjusted developmental reference ranges:

Age Classification pH PaCO2 (mmHg) PaO2 (mmHg) HCO3- (mEq/L) Base Excess Target SpO2

Preterm infant Treatment target varies by gestation, postnatal age, disease, cerebral risk, and ventilation strategy Avoid interpreting a permissive target as a normal reference interval

Term neonate PaO2 and saturation change during transition and with ductal or pulmonary vascular physiology Use postnatal-age and diagnosis-specific targets

Older infant / child A conventional arterial reference is often near pH 7.35–7.45 and PaCO2 35–45 mmHg Use the reporting laboratory and clinical protocol; PaO2/SpO2 goals vary with disease

Permissive hypercapnia: A neonatal lung-protective pathway may accept a higher PaCO2 if pH, cerebral status, pulmonary vascular physiology, and hemodynamics remain acceptable. It is a prescribed treatment range, not a universal normal value or a guarantee against lung injury.

Systematic Acid-Base Evaluation & Compensation Dynamics

Evaluate pH: Acidemia (< 7.35; in preterms < 7.25) vs. Alkalemia (> 7.45).

Evaluate Respiratory Component (PaCO2): If pH is acidic and PaCO2 > 45 mmHg, primary respiratory acidosis is present.

Evaluate Metabolic Component (HCO3-): If pH is acidic and HCO3- < 22 mEq/L, primary metabolic acidosis is present.

Determine Compensatory Response:

Acute Respiratory Acidosis: For every 10 mmHg increase in PaCO2 above 40, plasma HCO3- increases by 1 mEq/L (cellular buffer release).

Chronic Respiratory Acidosis (24–72 hours): For every 10 mmHg increase in PaCO2 above 40, plasma HCO3- increases by 3.5 to 4.0 mEq/L (renal tubular acid excretion and HCO3- reclamation).

Metabolic Acidosis (Winter's Formula): Expected compensatory PaCO2:

Expected PaCO2 = (1.5 × HCO3-) + 8 ± 2

If measured PaCO2 matches expected range: appropriate respiratory compensation.

If measured PaCO2 > expected: superimposed primary respiratory acidosis.

If measured PaCO2 < expected: superimposed primary respiratory alkalosis.

  • Worked Clinical Calculation: Acid-Base & Winter's Modeling
  • Clinical Scenario

A 7-year-old child with a 3-day history of diabetic ketoacidosis (DKA) and tachypnea presents to the emergency department. Arterial blood gas results:

  • pH = 7.18
  • PaCO2 = 20 mmHg
  • PaO2 = 96 mmHg
  • HCO3- = 8 mEq/L
  • Base Excess = -18 mEq/L
  • Step-by-Step Analysis

Acidemia: pH = 7.18 (< 7.35).

Primary Disturbance: HCO3- = 8 mEq/L (< 22), confirming severe primary metabolic acidosis.

Calculate Expected PaCO2 using Winter's Formula: Expected PaCO2 = (1.5 × 8) + 8 ± 2 = 12 + 8 ± 2 = 20 ± 2 mmHg (Range: 18 to 22 mmHg)

Comparison: Measured PaCO2 = 20 mmHg, which falls exactly within the predicted range (18 to 22 mmHg).

Interpretation: Primary metabolic acidosis with appropriate respiratory compensation (Kussmaul breathing). The measured PaCO2 does not show an additional primary respiratory disorder.

  • NPS Exam Traps
  • NPS Exam Trap 1: Intermediate UAC Position

A UAC tip at T10 or L1 overlaps the major abdominal branch-vessel region. Do not use the line merely because it draws blood. Reposition it to the institution's accepted high or low zone and reconfirm the tip before use.

NPS Exam Trap 2: Managing Arterial Vasospasm ('High Line Toe')

A pale, cool, or cyanotic foot after UAC placement requires immediate perfusion assessment and neonatal-team notification. Stop nonessential infusion through the catheter, check position and competing causes, and follow the catheter-removal or repositioning protocol. Do not delay definitive catheter management for the older practice of warming the opposite limb, and never apply direct heat to ischemic skin.

NPS Exam Trap 3: Capillary PO2 for FiO2 Titration

If an exam question asks how to adjust FiO2 based on a capillary blood gas report with a capillary PO2 of 38 mmHg, do NOT increase the FiO2. Look at the patient's pulse oximetry (SpO2) or obtain an arterial sample. Capillary PO2 is not a reliable substitute for arterial PaO2 when titrating oxygen.